These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4208047)

  • 21. Transition temperatures in the sensitivity of Escherichia coli B/r to lysozyme.
    Scheie P
    Biochim Biophys Acta; 1982 Jun; 716(3):420-3. PubMed ID: 6810952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of chemotype on Escherichia coli interactions with bactericidal proteins.
    Zubova SV; Grachev SV; Prokhorenko IR
    Bull Exp Biol Med; 2007 Aug; 144(2):224-6. PubMed ID: 18399286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neutralization of human serum lysozyme by sodium polyanethol sulfonate but not by sodium amylosulfate.
    Traub WH; Fukushima PI
    J Clin Microbiol; 1978 Sep; 8(3):306-12. PubMed ID: 212454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A highly efficient procedure for the quantitative formation of intact and viable lysozyme spheroplasts from Escherichia coli.
    Marvin HJ; Witholt B
    Anal Biochem; 1987 Aug; 164(2):320-30. PubMed ID: 3118737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Change of resistance to lysozyme and ultrasonic disintegration of the mycelium of Streptomyces griseus under the influence of chelating agents and polyvalent cations.
    Szeszák F; Szabó G; Erdei J; Müller F
    Can J Microbiol; 1968 Jul; 14(7):769-73. PubMed ID: 4971766
    [No Abstract]   [Full Text] [Related]  

  • 26. K-1 antigen of Escherichia coli: epidemiology and serum sensitivity of pathogenic strains.
    Pitt J
    Infect Immun; 1978 Oct; 22(1):219-24. PubMed ID: 103825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of purified lipopolysaccharide on the bactericidal reaction of human serum complement.
    Allen RJ; Scott GK
    J Gen Microbiol; 1980 Mar; 117(1):65-72. PubMed ID: 6993628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Osmotic fragility of lysozyme- and thiol-treated Lactobacillus plantarum.
    Habbal Z; Durr IF
    J Bacteriol; 1969 Dec; 100(3):1409-10. PubMed ID: 4982897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of lysozyme, ethylenediaminetetraacetate, magnesium and mannittol on spheroplast formation in Anacystis nidulans].
    Mineeva LA; Semënova LR; Gusev MV
    Mikrobiologiia; 1979; 48(4):693-8. PubMed ID: 113653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of intravenous ethanol on the bactericidal activity of human serum.
    Johnson WD; Stokes P; Kaye D
    Yale J Biol Med; 1969 Oct; 42(2):71-85. PubMed ID: 4914965
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of organic cations on the gram-negative cell wall and their bactericidal activity with ethylenediaminetetra-acetate and surface active agents.
    Voss JG
    J Gen Microbiol; 1967 Sep; 48(3):391-400. PubMed ID: 4964028
    [No Abstract]   [Full Text] [Related]  

  • 32. [Behavior of mesosomes at the time of attack of Bacillus subtilis by lysozyme in a hyper- or hypotonic medium].
    Ryter A; Frehel C; Ferrandes B
    C R Acad Hebd Seances Acad Sci D; 1967 Oct; 265(17):1259-62. PubMed ID: 4965552
    [No Abstract]   [Full Text] [Related]  

  • 33. [Serum resistance and "nephropathogenicity" of antigenetically defined E. coli strains. II. Behavior of different serum resistant bacilli in vitro].
    Henkel W
    Z Med Mikrobiol Immunol; 1971; 156(3):284-96. PubMed ID: 4934919
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of lysozyme or modified lysozyme fragments on DNA and RNA synthesis and membrane permeability of Escherichia coli.
    Pellegrini A; Thomas U; Wild P; Schraner E; von Fellenberg R
    Microbiol Res; 2000 Jul; 155(2):69-77. PubMed ID: 10950188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How does lysozyme penetrate through the bacterial outer membrane?
    Witholt B; Heerikhuizen HV; De Leij L
    Biochim Biophys Acta; 1976 Sep; 443(3):534-44. PubMed ID: 822877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In-vitro effect of edta-tris-lysozyme solutions on selected pathogenic bacteria.
    Wooley RE; Blue JL
    J Med Microbiol; 1975 Feb; 8(1):189-94. PubMed ID: 805241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of divalent cations on permeabilizer-induced lysozyme lysis of Pseudomonas aeruginosa.
    Ayres HM; Furr JR; Russell AD
    Lett Appl Microbiol; 1998 Dec; 27(6):372-4. PubMed ID: 9890756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inefficient bacteriolysis of Escherichia coli by serum from human neonates.
    Lassiter HA; Tanner JE; Miller RD
    J Infect Dis; 1992 Feb; 165(2):290-8. PubMed ID: 1730895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rufloxacin enhances susceptibility of Escherichia coli to leukocyte activity.
    Herrera I; Martinez P; Perez P; Martin M; Gomez-Lus ML; Prieto J
    J Chemother; 1995 Nov; 7 Suppl 4():36-7. PubMed ID: 8904099
    [No Abstract]   [Full Text] [Related]  

  • 40. Isolation of murein-free spheroplast ghosts from a strain of Escherichia coli K 12.
    de Corao M; Serrano JA; Leal JA; Puig J; Muñoz E
    Microbiol Esp; 1974; 27(3-4):283-98. PubMed ID: 4217872
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.